Guidant Defibrillator Recall News Archive
Boston Scientific posts Q4 net loss on charges
-Reuters
02/04/2008 - Medical device maker Boston Scientific Corp posted a fourth-quarter net loss on Monday as it took charges for restructuring operations, divesting assets and patent litigation. The company, which has focused on reducing costs and shedding non-core assets as it copes with downturns in its two key heart device markets, said the net loss was $458 million, or 31 cents a share. More:::
Boston Scientific Has Loss on Legal Expenses, Cuts
-Bloomberg
02/04/2008 - Boston Scientific Corp., the world's second-largest maker of heart devices, posted a loss on costs for legal expenses and job cuts. Sales rose more than analysts' estimated, boosting the shares in extended trading. More:::
If you or your loved one uses Guidant brand defibrillators, it is possible that you may experience problems with the device. If you have concerns about the recall consult with your doctor and then contact the Guidant defibrillator recall lawyers of Ennis & Ennis, P.A. for a free legal consultation.